Parallax Volatility Advisers’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Parallax Volatility Advisers’s Portfolio SGMO Stock Details SGMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-26,500	Closed	-$199K	–	3131
2021 Q4	$199K	Sell	26,500 -81,000	-75%	-$704K	﹤0.01%	1653
2021 Q3	$969K	Sell	107,500 -98,800	-48%	-$977K	﹤0.01%	1346
2021 Q2	$2.47M	Buy	206,300 +133,400	+183%	+$1.51M	﹤0.01%	822
2021 Q1	$914K	Hold	72,900	–	–	﹤0.01%	852
2020 Q4	$1.14M	Buy	72,900 +42,900	+143%	+$503K	﹤0.01%	1403
2020 Q3	$284K	Buy	+30,000	New	+$324K	﹤0.01%	2422
2019 Q3	–	Sell	-17,500	Closed	-$188K	–	3322
2019 Q2	$188K	Buy	+17,500	New	+$186K	﹤0.01%	1741
2018 Q4	–	Sell	-59,600	Closed	-$1.01M	–	3828
2018 Q3	$1.01M	Buy	59,600 +35,000	+142%	+$532K	﹤0.01%	1260
2018 Q2	$349K	Buy	+24,600	New	+$409K	﹤0.01%	1329
2018 Q1	–	Sell	-35,000	Closed	-$574K	–	3968
2017 Q4	$574K	Hold	35,000	–	–	﹤0.01%	1451
2017 Q3	$525K	Hold	35,000	–	–	﹤0.01%	1241
2017 Q2	$308K	Buy	+35,000	New	+$225K	﹤0.01%	1347
2016 Q4	–	Sell	-145,800	Closed	-$675K	–	4012
2016 Q3	$675K	Buy	+145,800	New	+$742K	﹤0.01%	1388

Other funds holding SGMO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Parallax Volatility Advisers's SGMO Position: Q2 2021 in Review

Parallax Volatility Advisers sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q2 2021, closing a stake of 3,421 shares — an estimated $38.7K sold.

Parallax Volatility Advisers first reported a position in SGMO in Q2 2015 and held it in 8 quarters. The position peaked at $2.31M in Q2 2018. 197 funds tracked by Wall St. Rank hold SGMO as of Q2 2021.

Parallax Volatility Advisers reported no remaining SANGAMO THERAPEUTICS INC position as of Q2 2021 after selling out during the quarter.
Parallax Volatility Advisers sold 3,421 SANGAMO THERAPEUTICS INC shares in Q2 2021, an estimated $38.7K.
Parallax Volatility Advisers first reported a position in SANGAMO THERAPEUTICS INC in Q2 2015 and held it in 8 quarters.
Parallax Volatility Advisers's SANGAMO THERAPEUTICS INC position peaked at $2.31M in Q2 2018.
197 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q2 2021.

Based on Parallax Volatility Advisers's 13F filing for Q2 2021, filed 16 Aug 2021.